+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

From
From
Licensing Deals in Biotechnology 2019-2025 - Product Thumbnail Image

Licensing Deals in Biotechnology 2019-2025

  • Report
  • April 2025
  • 1250 Pages
  • Global
From
Collaboration Deals in Biotechnology 2019-2025 - Product Thumbnail Image

Collaboration Deals in Biotechnology 2019-2025

  • Report
  • April 2025
  • 1000 Pages
  • Global
From
From
From
Hidradenitis Suppurativa - Pipeline Insight, 2025 - Product Thumbnail Image

Hidradenitis Suppurativa - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 115 Pages
  • Global
From
From
Blood and Blood Components Market Report 2025 - Product Thumbnail Image

Blood and Blood Components Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Therapeutic Proteins Market Report 2025 - Product Thumbnail Image

Therapeutic Proteins Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Plasma Protein Therapeutics Market Report 2025 - Product Thumbnail Image

Plasma Protein Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Xenotransplantation Market Report 2025 - Product Thumbnail Image

Xenotransplantation Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
From
From
Loading Indicator